Catherine Brezault‐Bonnet
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Genomics and Diagnostics, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer(2009)57 cited
- → Hepatocarcinoma-Intestine-Pancreas/Pancreatic Associated Protein (HIP/PAP) Is Expressed and Secreted by Proliferating Ductules as well as by Hepatocarcinoma and Cholangiocarcinoma Cells(1999)46 cited
- → Chronomodulated Irinotecan, Oxaliplatin, and Leucovorin-Modulated 5-Fluorouracil as Ambulatory Salvage Therapy in Patients with Irinotecan- and Oxaliplatin-Resistant Metastatic Colorectal Cancer(2006)36 cited
- → Chronotherapy of Colorectal Liver Metastases(2002)17 cited
- → Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX)(2020)17 cited
- → Three-drug chronotherapy via hepatic artery as salvage treatment for patients with liver-only metastases from colorectal cancer(2005)7 cited
- → Chronomodulated (Chrono) vs constant (Cst) rate infusional 5-fluorouracil (FU) with or without cisplatin (CDDP) in patients with advanced or metastatic pancreatic cancer. A multicenter randomized trial of the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer (EORTC 05962)(2004)6 cited
- → Hepatic artery chronomodulated infusion of irinotecan, 5-fluorouracil and oxaliplatin against liver metastases in heavily pretreated patients with colorectal cancer(2004)3 cited
- → Cancer de l’estomac et du cardia(2006)